furegrelate has been researched along with Cardiovascular Stroke in 4 studies
furegrelate: structure given in UD 35:175:d
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nichols, WW | 1 |
| Mehta, J | 1 |
| Wargovich, TJ | 1 |
| Franzini, D | 1 |
| Lawson, D | 1 |
| O'Connor, KM | 1 |
| Friehling, TD | 1 |
| Kowey, PR | 1 |
| Gréen, K | 1 |
| Vesterqvist, O | 1 |
| Hock, CE | 1 |
| Phillips, GR | 1 |
| Lefer, AM | 1 |
4 other studies available for furegrelate and Cardiovascular Stroke
| Article | Year |
|---|---|
Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist.
Topics: Animals; Benzofurans; Bridged Bicyclo Compounds, Heterocyclic; Chemotaxis, Leukocyte; Creatine Kinas | 1989 |
The effect of thromboxane inhibition on vulnerability to ventricular fibrillation in the acute and chronic feline infarction models.
Topics: Acute Disease; Animals; Benzofurans; Cardiac Pacing, Artificial; Cats; Chronic Disease; Female; Male | 1989 |
In vivo synthesis of thromboxane and prostacyclin in man in health and disease. Data from GC-MS measurements of major urinary metabolites.
Topics: 6-Ketoprostaglandin F1 alpha; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Blood Vessel Pro | 1986 |
Protective action of a thromboxane synthetase inhibitor in preventing extension of infarct size in acute myocardial infarction.
Topics: Animals; Benzofurans; Disease Models, Animal; Male; Myocardial Infarction; Oxidoreductases; Rats; Ra | 1985 |